Molecular surveillance of chloroquine-resistant Plasmodium falciparum in sub-Saharan African countries after withdrawal of chloroquine for treatment of uncomplicated malaria: A systematic review

被引:11
|
作者
Njiro, Belinda J. [1 ]
Mutagonda, Ritah F. [1 ]
Chamani, Amisa T. [1 ]
Mwakyandile, Tosi [1 ]
Sabas, Deodatus [1 ]
Bwire, George M. [1 ]
机构
[1] Muhimbili Univ Hlth & Allied Sci, POB 65001, Dar Es Salaam, Tanzania
关键词
Chloroquine; Sub-Saharan Countries; Plasmodium falciparum; Pfcrt; Pfmdr1; ANTIMALARIAL-DRUG RESISTANCE; TRANSPORTER GENE; MARKERS; PFCRT; SUSCEPTIBILITY; LUMEFANTRINE; PREVALENCE; MUTATIONS; GENOTYPES; DISTRICT;
D O I
10.1016/j.jiph.2022.03.015
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: A wide spread of chloroquine resistance prompted its discontinued use for treatment of uncomplicated malaria in several African countries. However, disappearances of chloroquine-resistant parasites have been reported in areas with restricted use of chloroquine. This review reports the current prevalence of chloroquine-resistant Plasmodium falciparum using Pfcrt K76T and Pfmdr1 N86Y genotypes. Methods: A PROSPERO registered systematic review searched evidence from PubMed/MEDLINE, Science Direct and Google Scholar. The search included studies on chloroquine-resistant/ susceptible P. falciparum in humans between January 1st, 2000 and May 15th, 2020. The search was conducted on 15th of May, 2020. Results: Out of 519 searched records, 15 studies qualified for final analysis with 8040 samples genotyped for Pfcrt K76T. Of 8040, 43.6% (837/1572; 95%CI: -0.9 to 88.1%) carried resistant genotypes versus 23.0% (1477/ 6468; 95%CI: 15.7-30.2%) while for 4698 samples analyzed for Pfmdr1 N86Y, 52.4% (592/1090; 95%CI: 42.3-62.5%) had resistant genotypes versus 25.9% (1314/3608; 95%CI: 5.8-46.0%), before and after chloroquine withdrawal, respectively. The median time since chloroquine withdrawal to data collection was 7.0 (interquartile range: 4.5-13.5) years. Low prevalence of resistant genotypes (Pfcrt K76T) was reported in Zambia (0%) in 2013, Malawi (0.1%) in 2009, Tanzania (0.2%) in 2018 and Madagascar (0.3%) in 2007 with significant variations in the included studies. Conclusions: Chloroquine-resistant P. falciparum continues to disappear in countries with withdrawal of chloroquine. Areas with significant susceptible parasites, reintroduction of chloroquine can be considered, preferably in combination with other safe and affordable antimalarials. (c) 2022 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. CC_BY_NC_ND_4.0
引用
收藏
页码:550 / 557
页数:8
相关论文
共 26 条
  • [1] High-Dose Chloroquine for Treatment of Chloroquine-Resistant Plasmodium falciparum Malaria
    Ursing, Johan
    Rombo, Lars
    Bergqvist, Yngve
    Rodrigues, Amabelia
    Kofoed, Poul-Erik
    JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (08) : 1315 - 1321
  • [2] Chloroquine-resistant Plasmodium falciparum infections among UK travellers returning with malaria after chloroquine prophylaxis
    Sutherland, Colin J.
    Haustein, Thomas
    Gadalla, Nahla
    Armstrongi, Margaret
    Doherty, Justin F.
    Chiodini, Peter L.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (06) : 1197 - 1199
  • [3] Comparative efficacy of chloroquine/chlorpheniramine combination and mefloquine for the treatment of chloroquine-resistant Plasmodium falciparum malaria in Nigerian children
    Sowunmi, A
    Oduola, AMJ
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1997, 91 (06) : 689 - 693
  • [4] Artemether and lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa
    Ogutu, Bernhards
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (05) : 643 - 654
  • [5] Uncomplicated Plasmodium falciparum malaria in infants <5 kg: retrospective surveillance of hospital records in five Sub-Saharan African countries
    Maroufou J Alao
    Adama D Gbadoè
    Antoinette K Tshefu
    Martin Meremikwu
    Alfred B Tiono
    Marc Cousin
    Kamal Harried
    Malaria Journal, 11 (Suppl 1)
  • [6] Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine
    Oladosu O Oladipo
    Oyibo A Wellington
    Colin J Sutherland
    Diagnostic Pathology, 10
  • [7] Molecular surveillance for anti-malarial drug resistance and genetic diversity of Plasmodium falciparum after chloroquine and sulfadoxine-pyrimethamine withdrawal in Quibdo, Colombia, 2018
    Patricia Guerra, Angela
    Javier Olivera, Mario
    Jazmin Cortes, Liliana
    Chenet, Stella M.
    Macedo de Oliveira, Alexandre
    Lucchi, Naomi W.
    MALARIA JOURNAL, 2022, 21 (01)
  • [8] Polymorphisms in Pfcrt and Pfmdr-1 genes after five years withdrawal of chloroquine for the treatment of Plasmodium falciparum malaria in West Bengal, India
    Chatterjee, Moytrey
    Ganguly, Swagata
    Saha, Pabitra
    Guha, Subhasish Kamal
    Basu, Nandita
    Bera, Dilip K.
    Maji, Ardhendu Kumar
    INFECTION GENETICS AND EVOLUTION, 2016, 44 : 281 - 285
  • [9] Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries
    Drakeley, Chris
    Abdulla, Salim
    Agnandji, Selidji Todagbe
    Fernandes, Jose Francisco
    Kremsner, Peter
    Lell, Bertrand
    Mewono, Ludovic
    Bache, Bache Emmanuel
    Mihayo, Michael Gabriel
    Juma, Omar
    Tanner, Marcel
    Tahita, Marc Christian
    Tinto, Halidou
    Diallo, Salou
    Lompo, Palpouguini
    D'Alessandro, Umberto
    Ogutu, Bernhards
    Otieno, Lucas
    Otieno, Solomon
    Otieno, Walter
    Oyieko, Janet
    Asante, Kwaku Poku
    Dery, Dominic Bon-Ereme
    Adjei, George
    Adeniji, Elisha
    Atibilla, Dorcas
    Owusu-Agyei, Seth
    Greenwood, Brian
    Gesase, Samwel
    Lusingu, John
    Mahende, Coline
    Mongi, Robert
    Segeja, Method
    Adjei, Samuel
    Agbenyega, Tsiri
    Agyekum, Alex
    Ansong, Daniel
    Bawa, John Tanko
    Boateng, Harry Owusu
    Dandalo, Leonard
    Escamilla, Veronica
    Hoffman, Irving
    Maenje, Peter
    Martinson, Francis
    Carter, Terrell
    Leboulleux, Didier
    Kaslow, David C.
    Usuf, Effua
    Pircon, Jean-Yves
    Bahmanyar, Edith Roset
    MALARIA JOURNAL, 2017, 16
  • [10] Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults
    Sagara, Issaka
    Oduro, Abraham R.
    Mulenga, Modest
    Dieng, Yemou
    Ogutu, Bernhards
    Tiono, Alfred B.
    Mugyenyi, Peter
    Sie, Ali
    Wasunna, Monique
    Kain, Kevin C.
    Djimde, Abdoulaye A.
    Sarkar, Shirsendu
    Chandra, Richa
    Robbins, Jeffery
    Dunne, Michael W.
    MALARIA JOURNAL, 2014, 13